Detalles de la búsqueda
1.
Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-2020.
J Antimicrob Chemother
; 78(Suppl 1): i17-i25, 2023 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37130586
2.
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-2020.
J Antimicrob Chemother
; 78(Suppl 1): i8-i16, 2023 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37130584
3.
Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011-20.
J Antimicrob Chemother
; 78(Suppl 1): i37-i47, 2023 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37130588
4.
Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-2020.
J Antimicrob Chemother
; 78(Suppl 1): i26-i36, 2023 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37130587
5.
MLH1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional MLH1 epimutation.
Gynecol Oncol
; 171: 129-140, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36893489
6.
PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
J Antimicrob Chemother
; 77(5): 1444-1451, 2022 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35141750
7.
In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014-21).
J Antimicrob Chemother
; 77(12): 3414-3420, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36177825
8.
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.
J Antimicrob Chemother
; 77(11): 3035-3038, 2022 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35971759
9.
Use of Fosfomycin Etest To Determine In Vitro Susceptibility of Clinical Isolates of Enterobacterales Other than Escherichia coli, Nonfermenting Gram-Negative Bacilli, and Gram-Positive Cocci.
J Clin Microbiol
; 59(12): e0163521, 2021 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34495708
10.
In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
J Antimicrob Chemother
; 76(7): 1808-1814, 2021 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33792700
11.
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
J Antimicrob Chemother
; 76(11): 2815-2824, 2021 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378029
12.
Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
J Antimicrob Chemother
; 76(11): 2825-2832, 2021 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378044
13.
Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four In Vitro Testing Methods.
J Clin Microbiol
; 58(10)2020 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32817224
14.
Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
J Antimicrob Chemother
; 75(7): 1824-1832, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32294172
15.
In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Bacterial Pathogens Isolated from Patients in Canadian Hospitals from 2013 to 2017 as Part of the CANWARD Surveillance Study.
Antimicrob Agents Chemother
; 63(1)2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30373806
16.
In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli.
Antimicrob Agents Chemother
; 63(1)2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30397056
17.
Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16.
J Antimicrob Chemother
; 74(Suppl 4): iv39-iv47, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31505644
18.
Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study.
J Antimicrob Chemother
; 74(Suppl 4): iv48-iv54, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31505645
19.
Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
J Antimicrob Chemother
; 74(Suppl 4): iv64-iv71, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31505647
20.
42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study.
J Antimicrob Chemother
; 74(Suppl 4): iv5-iv21, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31505641